These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38769021)

  • 1. HIV and prior exposure to antiretroviral therapy alter tumour composition and tumour: T-cell associations in diffuse large B-cell lymphoma.
    Coelho J; Roush SM; Xu AM; Puranam K; Mponda M; Kasonkanji E; Mulenga M; Tomoka T; Galeotti J; Brownlee A; Ghadially H; Damania B; Painschab M; Merchant A; Gopal S; Fedoriw Y
    Br J Haematol; 2024 Jul; 205(1):194-206. PubMed ID: 38769021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infection and ART exposure affect tumor TCR repertoire of diffuse large B cell lymphoma.
    Roush SM; Coelho J; Xu AM; Puranam K; Mponda M; Kasonkanji E; Mulenga M; Tomoka T; Galeotti J; Brownlee A; Ghadially H; Chagomerana M; Damania B; Painschab M; Merchant A; Gopal S; Fedoriw Y
    JCI Insight; 2024 May; 9(13):. PubMed ID: 38781015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era.
    Besson C; Lancar R; Prevot S; Algarte-Genin M; Delobel P; Bonnet F; Meyohas MC; Partisani M; Oberic L; Gabarre J; Goujard C; Boue F; Coppo P; Costello R; Hendel-Chavez H; Mekerri N; Dos Santos G; Recher C; Delarue R; Casasnovas RO; Taoufik Y; Mounier N; Costagliola D;
    AIDS; 2017 Nov; 31(18):2493-2501. PubMed ID: 28926410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of baseline lymphoma and HIV characteristics in Malawi before and after implementation of universal antiretroviral therapy.
    Gondwe Y; Kudowa E; Tomoka T; Kasonkanji ED; Kaimila B; Zuze T; Mumba N; Kimani S; Mulenga M; Chimzimu F; Kampani C; Randall C; Lilly A; Gopal S; Fedoriw Y; Painschab M
    PLoS One; 2022; 17(9):e0273408. PubMed ID: 36048901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying transcriptional profiles and evaluating prognostic biomarkers of HIV-associated diffuse large B-cell lymphoma from Malawi.
    Fedoriw Y; Selitsky S; Montgomery ND; Kendall SM; Richards KL; Du W; Tomoka T; Mulenga M; Parker JS; Dave SS; Gopal S
    Mod Pathol; 2020 Aug; 33(8):1482-1491. PubMed ID: 32080349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era.
    Morton LM; Kim CJ; Weiss LM; Bhatia K; Cockburn M; Hawes D; Wang SS; Chang C; Altekruse SF; Engels EA; Cozen W
    Leuk Lymphoma; 2014 Mar; 55(3):551-7. PubMed ID: 23772639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short communication: spectrum of non-Hodgkin lymphoma in an urban Ryan White-funded clinic in the established antiretroviral era.
    Silverton A; Gunthel C; Adamski M; Mosunjac M; Nguyen ML
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):665-9. PubMed ID: 24707838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications.
    Baptista MJ; Tapia G; Muñoz-Marmol AM; Muncunill J; Garcia O; Montoto S; Gribben JG; Calaminici M; Martinez A; Veloza L; Martínez-Trillos A; Aldamiz T; Menarguez J; Terol MJ; Ferrandez A; Alcoceba M; Briones J; González-Barca E; Climent F; Muntañola A; Moraleda JM; Provencio M; Abrisqueta P; Abella E; Colomo L; García-Ballesteros C; Garcia-Caro M; Sancho JM; Ribera JM; Mate JL; Navarro JT
    Histopathology; 2022 Dec; 81(6):826-840. PubMed ID: 36109172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent expression of activation-induced cytidine deaminase in diffuse large B-cell lymphoma tissues from persons living with HIV.
    Shponka V; Reveles CY; Alam S; Jaramillo M; Maguire A; Rimsza LM; Kendrick S
    AIDS; 2020 Nov; 34(14):2025-2035. PubMed ID: 32773475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.
    Alame M; Pirel M; Costes-Martineau V; Bauchet L; Fabbro M; Tourneret A; De Oliveira L; Durand L; Roger P; Gonzalez S; Cacheux V; Rigau V; Szablewski V
    Virchows Arch; 2020 Jun; 476(6):891-902. PubMed ID: 31811434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse Large B-Cell Lymphoma in the Public-Sector of Johannesburg, South Africa, in the Era of Widescale Antiretroviral Therapy Use.
    Vaughan J; Perner Y; Wiggill T
    J Acquir Immune Defic Syndr; 2022 Dec; 91(4):335-342. PubMed ID: 35916644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era.
    Baptista MJ; Garcia O; Morgades M; Gonzalez-Barca E; Miralles P; Lopez-Guillermo A; Abella E; Moreno M; Sancho JM; Feliu E; Ribera JM; Navarro JT
    AIDS; 2015 Apr; 29(7):811-8. PubMed ID: 25730510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of
    Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [No Abstract]   [Full Text] [Related]  

  • 14. Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study.
    Keane C; Vari F; Hertzberg M; Cao KA; Green MR; Han E; Seymour JF; Hicks RJ; Gill D; Crooks P; Gould C; Jones K; Griffiths LR; Talaulikar D; Jain S; Tobin J; Gandhi MK
    Lancet Haematol; 2015 Oct; 2(10):e445-55. PubMed ID: 26686046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse large B cell lymphoma CD5-positive arising in an immune deficiency and immune dysregulation setting: A case report and brief review of the literature.
    Cristian M; Baz RA; Stoica AG; Așchie M; Ghinea MM; Deacu M; Boșoteanu M; Mitroi AF; Dobrin N; Iordache IE; Bălțătescu GI
    Medicine (Baltimore); 2023 Feb; 102(8):e33083. PubMed ID: 36827036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-associated macrophages in diffuse large B-cell lymphoma: the prognostic and therapeutic impact in a South African centre with high HIV seroprevalence.
    Vaughan J; Wiggill T; Mia Z; Patel M
    Immunol Res; 2024 Dec; 72(6):1393-1403. PubMed ID: 39259401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaustion of tumour-infiltrating T-cell receptor repertoire diversity is an age-dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphoma.
    Rieken J; Bernard V; Witte HM; Peter W; Merz H; Olschewski V; Hertel L; Lehnert H; Biersack H; von Bubnoff N; Feller AC; Gebauer N
    Br J Haematol; 2021 Apr; 193(1):138-149. PubMed ID: 32945554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma.
    Chen W; Liang W; He Y; Liu C; Chen H; Lv P; Yao Y; Zhou H
    Med Oncol; 2022 Jan; 39(4):44. PubMed ID: 35092504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma.
    Xu-Monette ZY; Wei L; Fang X; Au Q; Nunns H; Nagy M; Tzankov A; Zhu F; Visco C; Bhagat G; Dybkaer K; Chiu A; Tam W; Zu Y; Hsi ED; Hagemeister FB; Sun X; Han X; Go H; Ponzoni M; Ferreri AJM; Møller MB; Parsons BM; van Krieken JH; Piris MA; Winter JN; Li Y; Xu B; Albitar M; You H; Young KH
    Clin Cancer Res; 2022 Mar; 28(5):972-983. PubMed ID: 34980601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The feature of distribution and clonality of TCR γ/δ subfamilies T cells in patients with B-cell non-Hodgkin lymphoma.
    Wang L; Xu M; Wang C; Zhu L; Hu J; Chen S; Wu X; Li B; Li Y
    J Immunol Res; 2014; 2014():241246. PubMed ID: 24963496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.